PPARA and metabolic dysfunction-associated steatotic liver disease: In line with reduced PPARα expression reported in MASLD/MASH patients, both the qPCR and western blot also reveal decreased PPARα expression in the WT mice following 6-week CDAHFD diet (Francque et al., 2015).